Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
Family Medicine|June 1, 1995
Family practice residents' learning needs and beliefs about office-based psychological counselingD J Butler, J J Seidl, R L Holloway, et al.Pneumologie (Stuttgart, Germany)|January 20, 2021
[Organ Bath Experiments on Human Pulmonary Vessels: Assessment of Drug Efficacy for Treatment of Pulmonary Arterial Hypertension]C Stadlbauer, S Golovchenko, L Englert, et al.Bone Marrow Transplantation|December 6, 2005
Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CMLB Horn, L-A Baxter-Lowe, L Englert, et al.Journal of Molecular Graphics & Modelling|December 28, 2016
CHARMM force field parameters for 2'-hydroxybiphenyl-2-sulfinate, 2-hydroxybiphenyl, and related analogsYue Yu, Ishan A Fursule, Landon C Mills, et al.Annals of the Royal College of Surgeons of England|June 30, 2009
Introduction of a day-case laparoscopic cholecystectomy service in the UK: a critical analysis of factors influencing same-day discharge and contact with primary care providersC D Briggs, G B Irving, C D Mann, et al.Journal of Bacteriology|November 25, 2010
Chemotaxis to the quorum-sensing signal AI-2 requires the Tsr chemoreceptor and the periplasmic LsrB AI-2-binding proteinManjunath Hegde, Derek L Englert, Shanna Schrock, et al.Physics in Medicine and Biology|October 29, 2015
High spatial resolution dosimetric response maps for radiotherapy ionization chambers measured using kilovoltage synchrotron radiationD J Butler, A W Stevenson, T E Wright, et al.Physics in Medicine and Biology|July 2, 2016
Comparison between the TRS-398 code of practice and the TG-51 dosimetry protocol for flattening filter free beamsJ E Lye, D J Butler, C P Oliver, et al.Medical Physics|May 3, 2014
Absolute x-ray dosimetry on a synchrotron medical beam line with a graphite calorimeterP D Harty, J E Lye, G Ramanathan, et al.Pulmonary Pharmacology & Therapeutics|December 28, 2020
Evaluation of the combination of endothelin receptor antagonists (ERA) and phosphodiesterase-5 inhibitors for the treatment of pulmonary arterial hypertension (PAH) in pathologic human pulmonary arteries in an ex-vivo organ bath modelL Englert, C Stadlbauer, M Spaeth, et al.Pageof 6